COVIVIO (COV.PA) Stock Fundamental Analysis
EPA:COV - FR0000064578 - REIT
55.9 EUR
+0.25 (+0.45%)
COV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 41 industry peers in the Diversified REITs industry. There are concerns on the financial health of COV while its profitability can be described as average. COV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
COV had positive earnings in the past year.
In the past year COV had a positive cash flow from operations.
Of the past 5 years COV 4 years were profitable.
In the past 5 years COV always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of COV (1.63%) is comparable to the rest of the industry.
COV has a Return On Equity (5.08%) which is in line with its industry peers.
COV has a Return On Invested Capital of 3.21%. This is comparable to the rest of the industry: COV outperforms 51.22% of its industry peers.
COV had an Average Return On Invested Capital over the past 3 years of 2.97%. This is in line with the industry average of 3.48%.
The last Return On Invested Capital (3.21%) for COV is above the 3 year average (2.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROIC | 3.21% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
1.3 Margins
COV has a Profit Margin (30.46%) which is comparable to the rest of the industry.
COV's Profit Margin has declined in the last couple of years.
COV's Operating Margin of 57.81% is on the low side compared to the rest of the industry. COV is outperformed by 65.85% of its industry peers.
In the last couple of years the Operating Margin of COV has remained more or less at the same level.
Looking at the Gross Margin, with a value of 74.42%, COV is in line with its industry, outperforming 53.66% of the companies in the same industry.
COV's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 57.81% | ||
| PM (TTM) | 30.46% | ||
| GM | 74.42% |
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so COV is destroying value.
COV has more shares outstanding than it did 1 year ago.
COV has more shares outstanding than it did 5 years ago.
COV has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.53, we must say that COV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of COV (0.53) is worse than 70.73% of its industry peers.
The Debt to FCF ratio of COV is 28.44, which is on the high side as it means it would take COV, 28.44 years of fcf income to pay off all of its debts.
COV has a Debt to FCF ratio of 28.44. This is in the lower half of the industry: COV underperforms 75.61% of its industry peers.
A Debt/Equity ratio of 1.07 is on the high side and indicates that COV has dependencies on debt financing.
COV has a worse Debt to Equity ratio (1.07) than 78.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.44 | ||
| Altman-Z | 0.53 |
ROIC/WACC0.56
WACC5.72%
2.3 Liquidity
A Current Ratio of 0.76 indicates that COV may have some problems paying its short term obligations.
COV's Current ratio of 0.76 is fine compared to the rest of the industry. COV outperforms 65.85% of its industry peers.
A Quick Ratio of 0.69 indicates that COV may have some problems paying its short term obligations.
COV's Quick ratio of 0.69 is fine compared to the rest of the industry. COV outperforms 65.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 |
3. Growth
3.1 Past
COV shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 5.98%.
COV shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -3.39% yearly.
COV shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.96%.
COV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.17% yearly.
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
3.2 Future
COV is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.84% yearly.
COV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.33% yearly.
EPS Next Y10.05%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
EPS Next 5YN/A
Revenue Next Year0.12%
Revenue Next 2Y2.42%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 12.13, which indicates a correct valuation of COV.
Based on the Price/Earnings ratio, COV is valued a bit cheaper than 70.73% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.03. COV is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.85 indicates a reasonable valuation of COV.
The rest of the industry has a similar Price/Forward Earnings ratio as COV.
When comparing the Price/Forward Earnings ratio of COV to the average of the S&P500 Index (22.63), we can say COV is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.13 | ||
| Fwd PE | 11.85 |
4.2 Price Multiples
COV's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, COV is valued a bit more expensive than the industry average as 60.98% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.86 | ||
| EV/EBITDA | 17 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y2.75%
EPS Next 3Y2.84%
5. Dividend
5.1 Amount
COV has a Yearly Dividend Yield of 6.24%, which is a nice return.
Compared to an average industry Dividend Yield of 5.44, COV pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, COV pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.24% |
5.2 History
The dividend of COV decreases each year by -1.54%.
Dividend Growth(5Y)-1.54%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
COV pays out 92.95% of its income as dividend. This is not a sustainable payout ratio.
DP92.95%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
EPA:COV (9/4/2025, 7:00:00 PM)
55.9
+0.25 (+0.45%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners39.95%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap6.24B
Analysts83.75
Price Target64.4 (15.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 6.24% |
Yearly Dividend0.72
Dividend Growth(5Y)-1.54%
DP92.95%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.04%
PT rev (3m)5.95%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.38%
EPS NY rev (3m)2.38%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)0.54%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.13 | ||
| Fwd PE | 11.85 | ||
| P/S | 4.55 | ||
| P/FCF | 15.86 | ||
| P/OCF | 6.22 | ||
| P/B | 0.76 | ||
| P/tB | 0.79 | ||
| EV/EBITDA | 17 |
EPS(TTM)4.61
EY8.25%
EPS(NY)4.72
Fwd EY8.44%
FCF(TTM)3.52
FCFY6.3%
OCF(TTM)8.99
OCFY16.09%
SpS12.29
BVpS73.66
TBVpS70.57
PEG (NY)1.21
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.63% | ||
| ROE | 5.08% | ||
| ROCE | 3.59% | ||
| ROIC | 3.21% | ||
| ROICexc | 3.42% | ||
| ROICexgc | 3.48% | ||
| OM | 57.81% | ||
| PM (TTM) | 30.46% | ||
| GM | 74.42% | ||
| FCFM | 28.68% |
ROA(3y)-1.05%
ROA(5y)0.29%
ROE(3y)-3.48%
ROE(5y)0.76%
ROIC(3y)2.97%
ROIC(5y)2.68%
ROICexc(3y)3.08%
ROICexc(5y)2.79%
ROICexgc(3y)3.11%
ROICexgc(5y)2.81%
ROCE(3y)3.32%
ROCE(5y)3%
ROICexcg growth 3Y12.16%
ROICexcg growth 5Y0.31%
ROICexc growth 3Y11.77%
ROICexc growth 5Y0.14%
OM growth 3Y-1.46%
OM growth 5Y-1.11%
PM growth 3Y-61.53%
PM growth 5Y-38.78%
GM growth 3Y-2.18%
GM growth 5Y-0.89%
F-Score7
Asset Turnover0.05
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.07 | ||
| Debt/FCF | 28.44 | ||
| Debt/EBITDA | 9.39 | ||
| Cap/Depr | 417.19% | ||
| Cap/Sales | 44.51% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 106.87% | ||
| Profit Quality | 94.14% | ||
| Current Ratio | 0.76 | ||
| Quick Ratio | 0.69 | ||
| Altman-Z | 0.53 |
F-Score7
WACC5.72%
ROIC/WACC0.56
Cap/Depr(3y)709.28%
Cap/Depr(5y)708.5%
Cap/Sales(3y)50.08%
Cap/Sales(5y)56.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)5.98%
EPS 3Y0.91%
EPS 5Y-3.39%
EPS Q2Q%6.25%
EPS Next Y10.05%
EPS Next 2Y2.75%
EPS Next 3Y2.84%
EPS Next 5YN/A
Revenue 1Y (TTM)27.96%
Revenue growth 3Y9.01%
Revenue growth 5Y1.17%
Sales Q2Q%-30.61%
Revenue Next Year0.12%
Revenue Next 2Y2.42%
Revenue Next 3Y3.33%
Revenue Next 5YN/A
EBIT growth 1Y-0.73%
EBIT growth 3Y7.42%
EBIT growth 5Y0.05%
EBIT Next Year11.8%
EBIT Next 3Y7.1%
EBIT Next 5Y7.65%
FCF growth 1Y42.08%
FCF growth 3YN/A
FCF growth 5Y31.13%
OCF growth 1Y30.56%
OCF growth 3Y12.5%
OCF growth 5Y4.86%